Live from the NIH registry
Studies recruiting near Asheville right now
Top 25 of 121 recruiting studies, sorted by proximity — each links to its official registry page
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Western Carolina Retinal Associate PA — Asheville, North Carolina (2.1 mi)
· Sponsor: Genentech, Inc.
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
Metastatic Castration-Resistant Prostate Cancer
Phase 2
Interventional 200 participants sought
Messino Cancer Center — Asheville, North Carolina (2.1 mi)
· Sponsor: Zenith Epigenetics
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: National Cancer Institute (NCI)
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
Keratoconus, Ectasia of Cornea
Phase 3
Interventional 485 participants sought
Woolfson Eye Institute — Asheville, North Carolina (2.1 mi)
· Sponsor: Woolfson Eye Institute
The CONFORM Pivotal Trial
Atrial Fibrillation, Stroke
N/A
Interventional 1,600 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: Conformal Medical, Inc
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Graves Disease
Phase 3
Interventional 300 participants sought
Site-038 — Asheville, North Carolina (2.1 mi)
· Sponsor: Biohaven Therapeutics Ltd.
Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome
Down Syndrome (DS), Keratoconus
Phase 3
Interventional 225 participants sought
Woolfson Eye Institute — Asheville, North Carolina (2.1 mi)
· Sponsor: Woolfson Eye Institute
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
Brain Metastases
Phase 3
Interventional 206 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: Canadian Cancer Trials Group
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation
Atrial Fibrillation (AF), Persistant Atrial Fibrillation
N/A
Interventional 699 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: Boston Scientific Corporation
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: NRG Oncology
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD
Phase 3
Interventional 284 participants sought
Adverum Clinical Site 196 — Asheville, North Carolina (2.1 mi)
· Sponsor: Adverum Biotechnologies, Inc.
Exactech Shoulder Post Market Clinical Follow-up Study
Osteo Arthritis Shoulders, Osteonecrosis
N/A
Observational 20,000 participants sought
Southeastern Sports Medicine and Orthopedics — Asheville, North Carolina (2.1 mi)
· Sponsor: Exactech
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma
Phase 3
Interventional 62 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: Children's Oncology Group
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma
Phase 2
Interventional 80 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: Children's Oncology Group
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Non-small Cell Lung Cancer
Phase 2, Phase 3
Interventional 1,260 participants sought
Fletcher Hospital, Inc. dba AdventHealth Hendersonville — Hendersonville, North Carolina (18.2 mi)
· Sponsor: BioNTech SE
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
Asthma
Phase 2
Interventional 540 participants sought
Research Site — Asheville, North Carolina (2.1 mi)
· Sponsor: AstraZeneca
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
Non-Small Cell Lung Cancer
Phase 3
Interventional 860 participants sought
Research Site — Asheville, North Carolina (2.1 mi)
· Sponsor: AstraZeneca
Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator
Chronic Pain
N/A
Observational 2,000 participants sought
Premier Pain Solutions — Asheville, North Carolina (2.1 mi)
· Sponsor: Abbott Medical Devices
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: NRG Oncology
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Age-Related Macular Degeneration, Geographic Atrophy
N/A
Interventional 125 participants sought
Western Carolina Retinal Associates — Asheville, North Carolina (2.1 mi)
· Sponsor: VisionCare, Inc.
Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects
Asthma
N/A
Observational 160 participants sought
Allergy Partners Clinical Research — Asheville, North Carolina (2.1 mi)
· Sponsor: Biometry Inc
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Phase 3
Interventional 466 participants sought
Margaret R Pardee Memorial Hospital — Hendersonville, North Carolina (18.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Messino Cancer Centers Asheville — Asheville, North Carolina (2.1 mi)
· Sponsor: Amgen
Empowering Young Parents: Building Healthy Relationships Study
Gender-based Violence, Intimate Partner Violence
N/A
Interventional 600 participants sought
Children & Family Resource Center — Hendersonville, North Carolina (18.2 mi)
· Sponsor: RTI International
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial Meningioma, Recurrent Meningioma
Phase 2
Interventional 124 participants sought
AdventHealth Infusion Center Asheville — Asheville, North Carolina (2.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology